Chieh-Lung Cheng
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 09, 2025
Time to progression is a simple and robust prognostic factor for survival in relapsed or refractory diffuse large B-cell lymphoma.Chieh-Lung Cheng, Tai-Chung Huang, Yu-Hsuan Tuan
|Jul 18, 2024
Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis.Chieh-Lung Cheng, You-Yu Lin, Chia-Lang Hsu
|Jan 05, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.Chieh-Lung Cheng, Po-Ting Yeh, Wei-Quan Fang
|Dec 08, 2022
Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.Chieh-Lung Cheng, Chi-Yuan Yao, Po-Hao Huang
|Jul 06, 2021
Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma.Chieh-Lung Cheng, Wei-Quan Fang, Yu-Jen Lin
|Apr 11, 2020
Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.Chieh-Lung Cheng, Sheng-Chuan Huang, Jia-Hong Chen
Pageof 2
Frequent Collaborators
1 joint publications
Chi-Yuan Yao
1 joint publications
Wei-Quan Fang
1 joint publications
Shan-Chi Yu
1 joint publications
Po-Ting Yeh
1 joint publications
Wei-Li Ma
1 joint publications
Chia-Lang Hsu
1 joint publications
Shiou-Hwei Yeh
1 joint publications
Hwei-Fang Tien
1 joint publications
Tai-Chung Huang
1 joint publications
Yu-Hsuan Tuan
